You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

iMCD

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor

Recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
  • +2 more
  • Beijing, China
  • +2 more
Apr 26, 2022

Idiopathic Multicentric Castleman's Disease Trial in Beijing (Zanubrutinib)

Recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Feb 5, 2021

ProducingNovel Symptom Burden Scale for People Living With

Not yet recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Research questions
  • (no location specified)
Aug 17, 2023

Castleman Disease, Castleman's Disease, Multicentric Trial in Little Rock, La Jolla, Philadelphia (Sirolimus)

Recruiting
  • Castleman Disease
  • Castleman's Disease, Multicentric
  • Little Rock, Arkansas
  • +3 more
Jan 6, 2023

Idiopathic Multicentric Castleman's Disease Trial in Lansing (Siltuximab)

Terminated
  • Idiopathic Multicentric Castleman's Disease
  • Lansing, Michigan
    Edward W. Sparrow Hospital
Apr 15, 2021

Idiopathic Multicentric Castleman's Disease Trial in Beijing (Bortezomib, Cyclophosphamide, Dexamethason)

Recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 9, 2019

Castleman Disease, Castleman's Disease, Giant Lymph Node Hyperplasia Trial in Worldwide

Recruiting
  • Castleman Disease
  • +8 more
    • Philadelphia, Pennsylvania
    • +9 more
    Dec 5, 2022

    Castleman Disease Collaborative Network Biobank

    Withdrawn
    • Castleman Disease
    • +8 more
    • Sample Collection
    • Philadelphia, Pennsylvania
      Castleman Disease Collaborative Network
    Jul 28, 2018